Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

North America Vitrification Market Size, Share & Industry Trends Analysis Report By Specimen (Oocytes (Devices, Kits & Consumables), Embryo (Devices, Kits & Consumables), and Sperm), By End-use, By Country and Growth Forecast, 2023 - 2030

Published Date : 30-Sep-2023

Pages: 100

Formats: PDF

The North America Vitrification Market would witness market growth of 16.8% CAGR during the forecast period (2023-2030).

Embryos and eggs are preserved for future use through vitrification when frozen. Techniques for vitrifying cells and tissues help preserve them, and they have a variety of applications in reproductive biology or regenerative medicine. It is employed, among other things, in preserving human fertility, storing cells for cell therapy, tissue regeneration, and gamete and embryo banking.

The need for assisted reproductive technologies (ARTs), a greater understanding of reproductive health issues, and an increase in service providers providing vitrification services are all expected to fuel the expansion of the market. This cryopreservation approach has become more effective because of its advantages over traditional slow-cooling methods. Additionally, given the current situation, most IVF facilities choose it because of its dependability and higher output.

The improvement of methods for preserving fertility sparked the creation of vitrification. This cutting-edge technique offers specimen preservation alternatives by reducing cryoprotectant exposure and shortening the preservation period. As a result, the market has seen profitable revenue growth. This has increased the widespread usage of vitrification devices. Delaying parenting is generally associated with sociodemographic factors, such as career and educational objectives, the growing influence of women's empowerment campaigns, the absence of a spouse, and financial constraints.

The Census Bureau said that between 1990 and 2019, the fertility rates in the United States steadily decreased. There were roughly 70.77 births per year for every 1,000 women aged between 15 to 44 in 1990. In that age group in 2019, there were approximately 58.21 births per 1,000 women. Further, the statistics showed that throughout the roughly 30-year period, the fertility rates of women aged 20 to 24 decreased by 43%, while those aged 35 to 39 soared by 67%. The AHR Act accomplishes this by outlining prohibited acts linked to aided human reproduction that could pose severe hazards to Canadians' health and safety or are thought unethical or inconsistent with Canadian values. The market for vitrification in North America would experience significant expansion due to such supportive government initiatives to encourage AHR procedures and the elevated risk of infertility.

The US market dominated the North America Vitrification Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $5,680.6 million by 2030. The Canada market is experiencing a CAGR of 19.4% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 18.4% during (2023 - 2030).

Based on Specimen, the market is segmented into Oocytes (Devices, Kits & Consumables), Embryo (Devices, Kits & Consumables), and Sperm. Based on End-use, the market is segmented into IVF Clinics, and Biobanks. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

Free Valuable Insights: The Vitrification Market is Predict to reach $24.1 Billion by 2030, at a CAGR of 17.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vitrolife AB, Genea Limited (Liverpool Partners Group), NidaCon International AB, Minitüb GmbH, Cryo Bio System (IMV Technologies Group), CooperSurgical Fertility & Genomic Solutions (The Cooper Companies, Inc.), FUJIFILM Irvine Scientific, Inc. (Fujifilm Holdings Corporation), Biotech, Inc., Kitazato Corporation and Shenzhen VitaVitro Biotech

Scope of the Study

Market Segments Covered in the Report:

By Specimen

  • Oocytes
    • Devices
    • Kits & Consumables
  • Embryo
    • Devices
    • Kits & Consumables
  • Sperm

By End-use

  • IVF Clinics
  • Biobanks

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players

List of Companies Profiled in the Report:

  • Vitrolife AB
  • Genea Limited (Liverpool Partners Group)
  • NidaCon International AB
  • Minitüb GmbH
  • Cryo Bio System (IMV Technologies Group)
  • CooperSurgical Fertility & Genomic Solutions (The Cooper Companies, Inc.)
  • FUJIFILM Irvine Scientific, Inc. (Fujifilm Holdings Corporation)
  • Biotech, Inc.
  • Kitazato Corporation
  • Shenzhen VitaVitro Biotech
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Vitrification Market, by Specimen
1.4.2 North America Vitrification Market, by End-use
1.4.3 North America Vitrification Market, by Country
1.5 Methodology for the research

Chapter 2. Market At a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis

Chapter 4. North America Vitrification Market, By Specimen
4.1 North America Oocytes Market, By Country
4.2 North America Vitrification Market, By Oocytes Type
4.2.1 North America Devices Market, By Country
4.2.2 North America Kits & Consumables Market, By Country
4.3 North America Embryo Market, By Country
4.4 North America Vitrification Market, By Embryo Type
4.4.1 North America Devices Market, By Country
4.4.2 North America Kits & Consumables Market, By Country
4.5 North America Sperm Market, By Country

Chapter 5. North America Vitrification Market, By End-use
5.1 North America IVF Clinics Market, By Country
5.2 North America Biobanks Market, By Country

Chapter 6. North America Vitrification Market, By Country
6.1 US Vitrification Market
6.1.1 US Vitrification Market, By Specimen
6.1.1.1 US Vitrification Market, By Oocytes Type
6.1.1.2 US Vitrification Market, By Embryo Type
6.1.2 US Vitrification Market, By End-use
6.2 Canada Vitrification Market
6.2.1 Canada Vitrification Market, By Specimen
6.2.1.1 Canada Vitrification Market, By Oocytes Type
6.2.1.2 Canada Vitrification Market, By Embryo Type
6.2.2 Canada Vitrification Market, By End-use
6.3 Mexico Vitrification Market
6.3.1 Mexico Vitrification Market, By Specimen
6.3.1.1 Mexico Vitrification Market, By Oocytes Type
6.3.1.2 Mexico Vitrification Market, By Embryo Type
6.3.2 Mexico Vitrification Market, By End-use
6.4 Rest of North America Vitrification Market
6.4.1 Rest of North America Vitrification Market, By Specimen
6.4.1.1 Rest of North America Vitrification Market, By Oocytes Type
6.4.1.2 Rest of North America Vitrification Market, By Embryo Type
6.4.2 Rest of North America Vitrification Market, By End-use

Chapter 7. Company Profiles
7.1 Vitrolife AB
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 SWOT Analysis
7.2 Genea Limited (Liverpool Partners Group)
7.2.1 Company Overview
7.2.2 SWOT Analysis
7.3 NidaCon International AB
7.3.1 Company Overview
7.3.2 SWOT Analysis
7.4 Minitüb GmbH
7.4.1 Company Overview
7.4.2 SWOT Analysis
7.5 Cryo Bio System (IMV Technologies Group)
7.5.1 Company Overview
7.5.2 SWOT Analysis
7.6 CooperSurgical Fertility & Genomic Solutions (The Cooper Companies, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Acquisition and Mergers:
7.6.6 SWOT Analysis
7.7 FUJIFILM Irvine Scientific, Inc. (Fujifilm Holdings Corporation)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches and Product Expansions:
7.7.5.2 Acquisition and Mergers:
7.7.5.3 Geographical Expansions:
7.7.6 SWOT Analysis
7.8 Biotech, Inc.
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Kitazato Corporation
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. Shenzhen VitaVitro Biotech
7.10.1 Company Overview
7.10.2 SWOT Analysis
TABLE 1 North America Vitrification Market, 2019 - 2022, USD Million
TABLE 2 North America Vitrification Market, 2023 - 2030, USD Million
TABLE 3 North America Vitrification Market, By Specimen, 2019 - 2022, USD Million
TABLE 4 North America Vitrification Market, By Specimen, 2023 - 2030, USD Million
TABLE 5 North America Oocytes Market, By Country, 2019 - 2022, USD Million
TABLE 6 North America Oocytes Market, By Country, 2023 - 2030, USD Million
TABLE 7 North America Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
TABLE 8 North America Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
TABLE 9 North America Devices Market, By Country, 2019 - 2022, USD Million
TABLE 10 North America Devices Market, By Country, 2023 - 2030, USD Million
TABLE 11 North America Kits & Consumables Market, By Country, 2019 - 2022, USD Million
TABLE 12 North America Kits & Consumables Market, By Country, 2023 - 2030, USD Million
TABLE 13 North America Embryo Market, By Country, 2019 - 2022, USD Million
TABLE 14 North America Embryo Market, By Country, 2023 - 2030, USD Million
TABLE 15 North America Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
TABLE 16 North America Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
TABLE 17 North America Devices Market, By Country, 2019 - 2022, USD Million
TABLE 18 North America Devices Market, By Country, 2023 - 2030, USD Million
TABLE 19 North America Kits & Consumables Market, By Country, 2019 - 2022, USD Million
TABLE 20 North America Kits & Consumables Market, By Country, 2023 - 2030, USD Million
TABLE 21 North America Sperm Market, By Country, 2019 - 2022, USD Million
TABLE 22 North America Sperm Market, By Country, 2023 - 2030, USD Million
TABLE 23 North America Vitrification Market, By End-use, 2019 - 2022, USD Million
TABLE 24 North America Vitrification Market, By End-use, 2023 - 2030, USD Million
TABLE 25 North America IVF Clinics Market, By Country, 2019 - 2022, USD Million
TABLE 26 North America IVF Clinics Market, By Country, 2023 - 2030, USD Million
TABLE 27 North America Biobanks Market, By Country, 2019 - 2022, USD Million
TABLE 28 North America Biobanks Market, By Country, 2023 - 2030, USD Million
TABLE 29 North America Vitrification Market, By Country, 2019 - 2022, USD Million
TABLE 30 North America Vitrification Market, By Country, 2023 - 2030, USD Million
TABLE 31 US Vitrification Market, 2019 - 2022, USD Million
TABLE 32 US Vitrification Market, 2023 - 2030, USD Million
TABLE 33 US Vitrification Market, By Specimen, 2019 - 2022, USD Million
TABLE 34 US Vitrification Market, By Specimen, 2023 - 2030, USD Million
TABLE 35 US Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
TABLE 36 US Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
TABLE 37 US Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
TABLE 38 US Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
TABLE 39 US Vitrification Market, By End-use, 2019 - 2022, USD Million
TABLE 40 US Vitrification Market, By End-use, 2023 - 2030, USD Million
TABLE 41 Canada Vitrification Market, 2019 - 2022, USD Million
TABLE 42 Canada Vitrification Market, 2023 - 2030, USD Million
TABLE 43 Canada Vitrification Market, By Specimen, 2019 - 2022, USD Million
TABLE 44 Canada Vitrification Market, By Specimen, 2023 - 2030, USD Million
TABLE 45 Canada Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
TABLE 46 Canada Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
TABLE 47 Canada Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
TABLE 48 Canada Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
TABLE 49 Canada Vitrification Market, By End-use, 2019 - 2022, USD Million
TABLE 50 Canada Vitrification Market, By End-use, 2023 - 2030, USD Million
TABLE 51 Mexico Vitrification Market, 2019 - 2022, USD Million
TABLE 52 Mexico Vitrification Market, 2023 - 2030, USD Million
TABLE 53 Mexico Vitrification Market, By Specimen, 2019 - 2022, USD Million
TABLE 54 Mexico Vitrification Market, By Specimen, 2023 - 2030, USD Million
TABLE 55 Mexico Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
TABLE 56 Mexico Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
TABLE 57 Mexico Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
TABLE 58 Mexico Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
TABLE 59 Mexico Vitrification Market, By End-use, 2019 - 2022, USD Million
TABLE 60 Mexico Vitrification Market, By End-use, 2023 - 2030, USD Million
TABLE 61 Rest of North America Vitrification Market, 2019 - 2022, USD Million
TABLE 62 Rest of North America Vitrification Market, 2023 - 2030, USD Million
TABLE 63 Rest of North America Vitrification Market, By Specimen, 2019 - 2022, USD Million
TABLE 64 Rest of North America Vitrification Market, By Specimen, 2023 - 2030, USD Million
TABLE 65 Rest of North America Vitrification Market, By Oocytes Type, 2019 - 2022, USD Million
TABLE 66 Rest of North America Vitrification Market, By Oocytes Type, 2023 - 2030, USD Million
TABLE 67 Rest of North America Vitrification Market, By Embryo Type, 2019 - 2022, USD Million
TABLE 68 Rest of North America Vitrification Market, By Embryo Type, 2023 - 2030, USD Million
TABLE 69 Rest of North America Vitrification Market, By End-use, 2019 - 2022, USD Million
TABLE 70 Rest of North America Vitrification Market, By End-use, 2023 - 2030, USD Million
TABLE 71 Key Information – Vitrolife AB
TABLE 72 Key Information – Genea Limited
TABLE 73 Key Information – NidaCon International AB
TABLE 74 Key Information – Minitüb GmbH
TABLE 75 Key Information – Cryo Bio System
TABLE 76 Key Information – CooperSurgical Fertility & Genomic Solutions
TABLE 77 Key Information – FUJIFILM Irvine Scientific, Inc.
TABLE 78 Key Information – Biotech, Inc.
TABLE 79 Key Information – Kitazato Corporation
TABLE 80 Key Information – Shenzhen VitaVitro Biotech

List of Figures
FIG 1 Methodology for the research
FIG 2 North America Vitrification Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Vitrification Market
FIG 4 Porter’s Five Forces Analysis – Vitrification Market
FIG 5 North America Vitrification Market, share By Specimen, 2022
FIG 6 North America Vitrification Market, share By Specimen, 2030
FIG 7 North America Vitrification Market, By Specimen, 2019 - 2030, USD Million
FIG 8 North America Vitrification Market, share By End-use, 2022
FIG 9 North America Vitrification Market, share By End-use, 2030
FIG 10 North America Vitrification Market, By End-use, 2019 - 2030, USD Million
FIG 11 North America Vitrification Market, share By Country, 2022
FIG 12 North America Vitrification Market, share By Country, 2030
FIG 13 North America Vitrification Market, By Country, 2019 - 2030, USD Million
FIG 14 SWOT Analysis: Vitrolife AB
FIG 15 SWOT Analysis: Genea Limited
FIG 16 SWOT Analysis: NidaCon International AB
FIG 17 SWOT Analysis: Minitüb GmbH
FIG 18 SWOT Analysis: Cryo Bio System
FIG 19 Recent strategies and developments: CooperSurgical Fertility & Genomic Solutions
FIG 20 SWOT Analysis: CooperSurgical Fertility & Genomic Solutions
FIG 21 Recent strategies and developments: FUJIFILM Irvine Scientific, Inc.
FIG 22 SWOT Analysis: FUJIFILM Irvine Scientific, Inc.
FIG 23 SWOT Analysis: Biotech, Inc.
FIG 24 SWOT Analysis: Kitazato Corporation
FIG 25 SWOT Analysis: Shenzhen VitaVitro Biotech

Purchase Full Report of
North America Vitrification Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL